Disease Burden of Pneumonia, Meningitis and Bacteremia Among Children in Japan: Pneumonet Japan

Pfizer

Status: Completed

Conditions: Pneumococcal Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT00757575

0887X1-4424

Details and patient eligibility

About

Streptococcus pneumoniae is a major cause of pneumonia, among infants and children in Japan and worldwideThis study plans to investigate the rate of invasive pneumococcal disease "IPD " and the rate of hospitalizations due to pneumonia in Okinawa and the Eastern half of Hokkaido Currently, only a limited information about pneumococcal disease burden is available in Japan.

Enrollment: 28,511 patients

Sex: All

Ages: 28 days to 60 months old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Eligibility Criteria

• Children residing in the surveillance area(s) aged 28 days to <60 months with clinical suspicion of pneumonia, meningitis and bacteremia who were admitted to the hospital.

Trial design

28,511 participants in 1 patient group

1